Dr. Lynne W Hsia, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 248 Perkins St, Sonoma, CA 95476 Phone: 707-938-7660 Fax: 707-721-1635 |
Dr. Jody Alison Culp Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 390 W Napa St, Sonoma, CA 95476 Phone: 707-938-5322 |
Dr. William Eastment Dempsey, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 390 W Napa St, Sonoma, CA 95476 Phone: 707-938-8575 Fax: 707-996-5041 |
Dr. Cherise Joy Wong, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 390 W Napa St, Sonoma, CA 95476 Phone: 707-938-5322 Fax: 707-938-5163 |
Dr. Timothy Dean Irish, DDS, MSD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 699 5th St W, Sonoma, CA 95476 Phone: 707-935-6878 Fax: 707-935-6811 |
Robert A Pack, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15000 Arnold Drive, Sonoma, CA 95431 Phone: 707-938-6556 |
Ryan Hillstead, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 574 3rd St W, Sonoma, CA 95476 Phone: 707-996-0813 |
Bradd Yoshioka, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 554 3rd St W, Sonoma, CA 95476 Phone: 707-996-3016 |
Dr. Carol Denise Berner, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 454 4th St W, Sonoma, CA 95476 Phone: 707-996-3737 Fax: 707-996-8840 |
Dr. Lee W Schaller, D.M.D. Dentist - Oral and Maxillofacial Pathology Medicare: Medicare Enrolled Practice Location: 378 Perkins St, Sonoma, CA 95476 Phone: 707-996-4519 Fax: 707-996-1707 |
Dr. Michael N Hillstead, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 574 Third Street West, Sonoma, CA 95476 Phone: 707-996-0813 Fax: 707-996-0815 |
Dr. Tyler Tilden Boynton, D.M.D. Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 378 Perkins St, Sonoma, CA 95476 Phone: 707-996-4519 |
News Archive
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
An analysis of 48,785 HIV-positive patients enrolled in China's National Free Antiretroviral Treatment Program over a five-year period revealed that "[h]alf of China's AIDS patients stopped responding to treatment over five years and didn't have access to the back-up drugs available in developed nations," according to an Annals of Internal Medicine study, Bloomberg reports.
Vertex Pharmaceuticals (Australia) Pty Ltd., announces the presentation of data from KALYDECO (ivacaftor) studies at the 10th Australasian Cystic Fibrosis Conference in Auckland, New Zealand, August 17 – 20, 2013, which further demonstrate the benefits of the medicine in people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.
Millions of Americans take medications for hypertension but do not achieve control of their blood pressure.
The First International Symposium on Nicotine Technology takes place today in Warsaw, Poland. The symposium looks at new and emerging technologies in the area of nicotine delivery and will be showcasing the latest advances in alternative nicotine delivery systems, next generation devices, and the science behind them.
› Verified 7 days ago